85-1436-45　［取扱停止］HIV-1 tat, Recombinant (Human Immunodeficiency Virus-1) 100ug　H6007-09

特徴

• Human immunodeficiency virus type-1 (HIV-1) regulatory Trans-Acting Transcription factor (TAT) plays an essential role in viral replication and infectivity. In addition, during acute infection, Tat is released extracellularly by infected cells and is taken up by neighboring cells where it transactivates viral replication and increases virus infectivity.
• Recombinant HIV-I TAT is a single, non-glycosylated, polypeptide chain containing 86 amino acids encoded by two exons and having chain having a molecular mass of 14kD.
• Specificity:Reacts with anti-Tat (HIV-1) antibodies from human, monkey, rabbit and mouse serum.
• Storage and Stability:Lyophilized powder may be stored at 4°C for short-term only. Reconstitute to nominal volume by adding sterile dH2O, aliquot and store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：100ug
• Source Antigen：Human, recombinant protein expressed in E. coli
• Grade：Highly Purified
• Purity：Purified by column chromatography (≥ 90% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain).Endotoxin: ≤ 0.1ng/ug (IEU/ug) of HIV-I TAT.
• Form：Supplied as a lyophilized powder. No additives.Reconstitution: Reconstitute with sterile 18MΩ-cm H2O > 0.1mg/ml.
• EU Commodity Code：30021019
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]